Kyle Haug A Ikido Pharma Inc. (AIKI) insider trading activity
Kyle Haug is Director of AIkido Pharma Inc.. Currently has a direct ownership of 24,409 shares of AIKI, which is worth approximately $92,754. The most recent transaction as insider was on Feb 10, 2025, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
24.4K
n/a
3M change
n/a
12M change
Total Value Held
$92,754
KH
Kyle Haug
Director
New York, NY